mRNA is opening up new ways to prevent, treat and possibly cure debilitating diseases, but as with any new therapeutic modality, the bench to bedside journey comes with uncertainties.
Samsung Biologics stands ready to develop, characterize, validate and transfer your technology from any stage of development, offering a one-stop solution to facilitate your path to commercial.
Check out this speaking session where @Eunseo Lee, Lead Manager in mRNA Manufacturing, presents on our mRNA platforms for next generation therapeutics, from concept to clinical validation and commercialization. [LINK]
#samsungbiologics #cdmo #cdo #mRNA #innovation #biopharma
'고품질을 보증하는 mRNA 플랫폼 개발 과정 및 삼성바이오로직스의 서비스'에 대한 삼성바이오로직스 mRNA 제조그룹 이은서 프로님의 발표를 확인해보세요.
00:00 Intro
00:03 Opening
00:22 mRNA-based Therapeutics Challenges
01:59 Technical Liaison for Developers’ Longer Journey
03:54 Manufacturing Flexibility
05:53 RNA Molecular Engineering Development
07:07 RNA Process Development Platform Based on QbD
09:01 List of Critical Quality Attributes
10:06 Process Parameters
11:11 Case Study: mRNA-LNP Lyophilization DoE
12:02 mRNA-LNP Lyophilization - Screening
14:27 mRNA-LNP Lyophilization - Oprimization
15:36 Samsung Biologics mRNA Manufacturing Capabilities
16:25 Samsung Biologics mRNA Proprietary Technology
17:17 Your first-choice mRNA CDMO partner